APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Chronic Idiopathic Constipation (CIC) Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Chronic Idiopathic Constipation (CIC) Drugs Market Analysis and Forecast 2026-2032

Report ID 173977960220 December 2025192 pages

Choose your research edition.

Industry ResearchChronic Idiopathic Constipation (CIC) Drugs Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Chronic Idiopathic Constipation (CIC) Drugs Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Chronic Idiopathic Constipation (CIC) Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chronic Idiopathic Constipation (CIC) Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Chronic Idiopathic Constipation (CIC) Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Chronic Idiopathic Constipation (CIC) Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Chronic Idiopathic Constipation (CIC) Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Chronic Idiopathic Constipation (CIC) Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Chronic Idiopathic Constipation (CIC) Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Chronic Idiopathic Constipation (CIC) Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Chronic Idiopathic Constipation (CIC) Drugs include Sanofi, Pfizer, GlaxoSmithKline, Bayer, Synergy Pharmaceuticals, Sucampo Pharmaceuticals, Salix Pharmaceuticals, Roche Holding and Progenics Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Chronic Idiopathic Constipation (CIC) Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Chronic Idiopathic Constipation (CIC) Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Chronic Idiopathic Constipation (CIC) Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Chronic Idiopathic Constipation (CIC) Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Chronic Idiopathic Constipation (CIC) Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Chronic Idiopathic Constipation (CIC) Drugs sales, projected growth trends, production technology, application and end-user industry.

Chronic Idiopathic Constipation (CIC) Drugs Segment by Company

Sanofi

Pfizer

GlaxoSmithKline

Bayer

Synergy Pharmaceuticals

Sucampo Pharmaceuticals

Salix Pharmaceuticals

Roche Holding

Progenics Pharmaceuticals

Ironwood Pharmaceuticals

Ferring International Center

Chugai Pharmaceutical

Actavis

Chronic Idiopathic Constipation (CIC) Drugs Segment by Type

Lubiprostone

Linaclotide

Others

Chronic Idiopathic Constipation (CIC) Drugs Segment by Application

Ambulatory Surgical Centres

Hospitals & Clinics

Long Term Care Centres

Others

Chronic Idiopathic Constipation (CIC) Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Idiopathic Constipation (CIC) Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chronic Idiopathic Constipation (CIC) Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Idiopathic Constipation (CIC) Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Chronic Idiopathic Constipation (CIC) Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Chronic Idiopathic Constipation (CIC) Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chronic Idiopathic Constipation (CIC) Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Lubiprostone Major Manufacturers Table 3. Linaclotide Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Ambulatory Surgical Centres Major Manufacturers Table 7. Hospitals & Clinics Major Manufacturers Table 8. Long Term Care Centres Major Manufacturers Table 9. Others Major Manufacturers Table 10. Chronic Idiopathic Constipation (CIC) Drugs Industry Trends Table 11. Chronic Idiopathic Constipation (CIC) Drugs Industry Drivers Table 12. Chronic Idiopathic Constipation (CIC) Drugs Industry Opportunities and Challenges Table 13. Chronic Idiopathic Constipation (CIC) Drugs Industry Restraints Table 14. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Region (2021-2026) Table 18. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Region (2027-2032) Table 19. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Region (2021-2026) & (K Units) Table 21. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Region (2027-2032) & (K Units) Table 22. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Region (2021-2026) Table 23. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Region (2027-2032) Table 24. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Manufacturers (2021-2026) Table 28. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Chronic Idiopathic Constipation (CIC) Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Chronic Idiopathic Constipation (CIC) Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Chronic Idiopathic Constipation (CIC) Drugs Manufacturers, Product Type & Application Table 32. Global Chronic Idiopathic Constipation (CIC) Drugs Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Chronic Idiopathic Constipation (CIC) Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Type (2021-2026) Table 39. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Type (2027-2032) Table 40. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021-2026) & (K Units) Table 42. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2027-2032) & (K Units) Table 43. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type (2021-2026) Table 44. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type (2027-2032) Table 45. Global Chronic Idiopathic Constipation (CIC) Drugs Price by Type (2021-2026) & (US$/Unit) Table 46. Global Chronic Idiopathic Constipation (CIC) Drugs Price by Type (2027-2032) & (US$/Unit) Table 47. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Application (2021-2026) Table 51. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Application (2027-2032) Table 52. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021-2026) & (K Units) Table 54. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2027-2032) & (K Units) Table 55. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application (2021-2026) Table 56. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application (2027-2032) Table 57. Global Chronic Idiopathic Constipation (CIC) Drugs Price by Application (2021-2026) & (US$/Unit) Table 58. Global Chronic Idiopathic Constipation (CIC) Drugs Price by Application (2027-2032) & (US$/Unit) Table 59. Sanofi Company Information Table 60. Sanofi Business Overview Table 61. Sanofi Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Sanofi Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 63. Sanofi Recent Development Table 64. Pfizer Company Information Table 65. Pfizer Business Overview Table 66. Pfizer Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Pfizer Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 68. Pfizer Recent Development Table 69. GlaxoSmithKline Company Information Table 70. GlaxoSmithKline Business Overview Table 71. GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 73. GlaxoSmithKline Recent Development Table 74. Bayer Company Information Table 75. Bayer Business Overview Table 76. Bayer Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Bayer Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 78. Bayer Recent Development Table 79. Synergy Pharmaceuticals Company Information Table 80. Synergy Pharmaceuticals Business Overview Table 81. Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 83. Synergy Pharmaceuticals Recent Development Table 84. Sucampo Pharmaceuticals Company Information Table 85. Sucampo Pharmaceuticals Business Overview Table 86. Sucampo Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Sucampo Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 88. Sucampo Pharmaceuticals Recent Development Table 89. Salix Pharmaceuticals Company Information Table 90. Salix Pharmaceuticals Business Overview Table 91. Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 93. Salix Pharmaceuticals Recent Development Table 94. Roche Holding Company Information Table 95. Roche Holding Business Overview Table 96. Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 98. Roche Holding Recent Development Table 99. Progenics Pharmaceuticals Company Information Table 100. Progenics Pharmaceuticals Business Overview Table 101. Progenics Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Progenics Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 103. Progenics Pharmaceuticals Recent Development Table 104. Ironwood Pharmaceuticals Company Information Table 105. Ironwood Pharmaceuticals Business Overview Table 106. Ironwood Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Ironwood Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 108. Ironwood Pharmaceuticals Recent Development Table 109. Ferring International Center Company Information Table 110. Ferring International Center Business Overview Table 111. Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 113. Ferring International Center Recent Development Table 114. Chugai Pharmaceutical Company Information Table 115. Chugai Pharmaceutical Business Overview Table 116. Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 118. Chugai Pharmaceutical Recent Development Table 119. Actavis Company Information Table 120. Actavis Business Overview Table 121. Actavis Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Actavis Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 123. Actavis Recent Development Table 124. North America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2021-2026) & (US$ Million) Table 125. North America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2027-2032) & (US$ Million) Table 126. North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021-2026) & (K Units) Table 127. North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2027-2032) & (K Units) Table 128. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 129. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 130. North America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2021-2026) & (US$ Million) Table 131. North America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2027-2032) & (US$ Million) Table 132. North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021-2026) & (K Units) Table 133. North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2027-2032) & (K Units) Table 134. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 135. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 136. North America Chronic Idiopathic Constipation (CIC) Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. North America Chronic Idiopathic Constipation (CIC) Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 138. North America Chronic Idiopathic Constipation (CIC) Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 139. North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 140. North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021-2026) & (K Units) Table 141. North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2027-2032) & (K Units) Table 142. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 143. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 144. United States Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032) & (US$ Million) Table 145. Canada Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032) & (US$ Million) Table 146. Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2021-2026) & (US$ Million) Table 147. Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2027-2032) & (US$ Million) Table 148. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021-2026) & (K Units) Table 149. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2027-2032) & (K Units) Table 150. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 151. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 152. Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2021-2026) & (US$ Million) Table 153. Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2027-2032) & (US$ Million) Table 154. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021-2026) & (K Units) Table 155. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2027-2032) & (K Units) Table 156. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 157. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 158. Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 162. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021-2026) & (K Units) Table 163. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2027-2032) & (K Units) Table 164. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 165. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 166. Germany Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032) & (US$ Million) Table 167. France Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032) & (US$ Million) Table 168. U.K. Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032) & (US$ Million) Table 169. Italy Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032) & (US$ Million) Table 170. Netherlands Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032) & (US$ Million) Table 171. China Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2021-2026) & (US$ Million) Table 172. China Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2027-2032) & (US$ Million) Table 173. China Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021-2026) & (K Units) Table 174. China Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2027-2032) & (K Units) Table 175. China Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 176. China Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 177. China Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2021-2026) & (US$ Million) Table 178. China Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2027-2032) & (US$ Million) Table 179. China Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021-2026) & (K Units) Table 180. China Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2027-2032) & (K Units) Table 181. China Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 182. China Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 183. Asia Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2021-2026) & (US$ Million) Table 184. Asia Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2027-2032) & (US$ Million) Table 185. Asia Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021-2026) & (K Units) Table 186. Asia Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2027-2032) & (K Units) Table 187. Asia Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 188. Asia Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 189. Asia Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2021-2026) & (US$ Million) Table 190. Asia Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2027-2032) & (US$ Million) Table 191. Asia Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021-2026) & (K Units) Table 192. Asia Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2027-2032) & (K Units) Table 193. Asia Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 194. Asia Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 195. Asia Chronic Idiopathic Constipation (CIC) Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. Asia Chronic Idiopathic Constipation (CIC) Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. Asia Chronic Idiopathic Constipation (CIC) Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. Asia Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 199. Asia Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021-2026) & (K Units) Table 200. Asia Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2027-2032) & (K Units) Table 201. Asia Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 202. Asia Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 203. Japan Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032) & (US$ Million) Table 204. South Korea Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032) & (US$ Million) Table 205. India Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032) & (US$ Million) Table 206. Australia Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032) & (US$ Million) Table 207. China Taiwan Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032) & (US$ Million) Table 208. Southeast Asia Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032) & (US$ Million) Table 209. SAMEA Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2021-2026) & (US$ Million) Table 210. SAMEA Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2027-2032) & (US$ Million) Table 211. SAMEA Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021-2026) & (K Units) Table 212. SAMEA Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2027-2032) & (K Units) Table 213. SAMEA Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 214. SAMEA Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 215. SAMEA Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2021-2026) & (US$ Million) Table 216. SAMEA Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2027-2032) & (US$ Million) Table 217. SAMEA Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021-2026) & (K Units) Table 218. SAMEA Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2027-2032) & (K Units) Table 219. SAMEA Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 220. SAMEA Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 221. SAMEA Chronic Idiopathic Constipation (CIC) Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 222. SAMEA Chronic Idiopathic Constipation (CIC) Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 223. SAMEA Chronic Idiopathic Constipation (CIC) Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 224. SAMEA Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 225. SAMEA Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021-2026) & (K Units) Table 226. SAMEA Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2027-2032) & (K Units) Table 227. SAMEA Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 228. SAMEA Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 229. Brazil Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032) & (US$ Million) Table 230. Argentina Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032) & (US$ Million) Table 231. Chile Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032) & (US$ Million) Table 232. Colombia Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032) & (US$ Million) Table 233. Peru Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032) & (US$ Million) Table 234. Saudi Arabia Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032) & (US$ Million) Table 235. Israel Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032) & (US$ Million) Table 236. UAE Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032) & (US$ Million) Table 237. Turkey Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032) & (US$ Million) Table 238. Iran Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032) & (US$ Million) Table 239. Egypt Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032) & (US$ Million) Table 240. Key Raw Materials Table 241. Raw Materials Key Suppliers Table 242. Chronic Idiopathic Constipation (CIC) Drugs Distributors List Table 243. Chronic Idiopathic Constipation (CIC) Drugs Customers List Table 244. Research Programs/Design for This Report Table 245. Authors List of This Report Table 246. Secondary Sources Table 247. Primary Sources List of Figures Figure 1. Chronic Idiopathic Constipation (CIC) Drugs Image Figure 2. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Lubiprostone Image Figure 5. Linaclotide Image Figure 6. Others Image Figure 7. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 9. Ambulatory Surgical Centres Image Figure 10. Hospitals & Clinics Image Figure 11. Long Term Care Centres Image Figure 12. Others Image Figure 13. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032) & (US$ Million) Figure 15. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Region (2021-2032) Figure 18. Global Chronic Idiopathic Constipation (CIC) Drugs Sales (2021-2032) & (K Units) Figure 19. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Chronic Idiopathic Constipation (CIC) Drugs Sales YoY (2021-2032) & (K Units) Figure 22. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales YoY (2021-2032) & (K Units) Figure 23. China Chronic Idiopathic Constipation (CIC) Drugs Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Chronic Idiopathic Constipation (CIC) Drugs Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales YoY (2021-2032) & (K Units) Figure 26. Global Chronic Idiopathic Constipation (CIC) Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Chronic Idiopathic Constipation (CIC) Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Type (2021-2032) Figure 32. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type (2021-2032) Figure 35. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Application (2021-2032) Figure 38. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application (2021-2032) Figure 41. North America Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Type (2021-2032) Figure 42. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Type (2021-2032) Figure 43. North America Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Application (2021-2032) Figure 44. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Application (2021-2032) Figure 45. North America Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Country (2021-2032) Figure 46. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Country (2021-2032) Figure 47. Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Type (2021-2032) Figure 48. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Type (2021-2032) Figure 49. Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Application (2021-2032) Figure 50. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Application (2021-2032) Figure 51. Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Country (2021-2032) Figure 52. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Country (2021-2032) Figure 53. China Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Type (2021-2032) Figure 54. China Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Type (2021-2032) Figure 55. China Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Application (2021-2032) Figure 56. China Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Application (2021-2032) Figure 57. Asia Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Type (2021-2032) Figure 58. Asia Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Type (2021-2032) Figure 59. Asia Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Application (2021-2032) Figure 60. Asia Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Application (2021-2032) Figure 61. Asia Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Country (2021-2032) Figure 62. Asia Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Country (2021-2032) Figure 63. SAMEA Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Type (2021-2032) Figure 64. SAMEA Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Type (2021-2032) Figure 65. SAMEA Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Application (2021-2032) Figure 66. SAMEA Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Application (2021-2032) Figure 67. SAMEA Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Country (2021-2032) Figure 68. SAMEA Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Country (2021-2032) Figure 69. Chronic Idiopathic Constipation (CIC) Drugs Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Chronic Idiopathic Constipation (CIC) Drugs Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Lubiprostone
  • Linaclotide
  • Others
Applications
  • Ambulatory Surgical Centres
  • Hospitals & Clinics
  • Long Term Care Centres
  • Others
Companies covered
  • Sanofi
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • Synergy Pharmaceuticals
  • Sucampo Pharmaceuticals
  • Salix Pharmaceuticals
  • Roche Holding
  • Progenics Pharmaceuticals
  • Ironwood Pharmaceuticals
  • Ferring International Center
  • Chugai Pharmaceutical
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Chronic Idiopathic Constipation (CIC) Drugs Market by Type
  3. 1.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Lubiprostone
  5. 1.2.3 Linaclotide
  6. 1.2.4 Others
  7. 1.3 Chronic Idiopathic Constipation (CIC) Drugs Market by Application
  8. 1.3.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Ambulatory Surgical Centres
  10. 1.3.3 Hospitals & Clinics
  11. 1.3.4 Long Term Care Centres
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Chronic Idiopathic Constipation (CIC) Drugs Market Dynamics
  1. 2.1 Chronic Idiopathic Constipation (CIC) Drugs Industry Trends
  2. 2.2 Chronic Idiopathic Constipation (CIC) Drugs Industry Drivers
  3. 2.3 Chronic Idiopathic Constipation (CIC) Drugs Industry Opportunities and Challenges
  4. 2.4 Chronic Idiopathic Constipation (CIC) Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region
  3. 3.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Region
  9. 3.4.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Manufacturers
  2. 4.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Chronic Idiopathic Constipation (CIC) Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Manufacturers
  6. 4.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Chronic Idiopathic Constipation (CIC) Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Chronic Idiopathic Constipation (CIC) Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Chronic Idiopathic Constipation (CIC) Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Chronic Idiopathic Constipation (CIC) Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Chronic Idiopathic Constipation (CIC) Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market CR5 and HHI
  16. 4.8.2 2025 Chronic Idiopathic Constipation (CIC) Drugs Tier 1, Tier 2, and Tier 3
5 Chronic Idiopathic Constipation (CIC) Drugs Market by Type
  1. 5.1 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type
  2. 5.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type
  6. 5.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Chronic Idiopathic Constipation (CIC) Drugs Price by Type
6 Chronic Idiopathic Constipation (CIC) Drugs Market by Application
  1. 6.1 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application
  2. 6.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application
  6. 6.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Chronic Idiopathic Constipation (CIC) Drugs Price by Application
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Pfizer
  8. 7.2.1 Pfizer Company Information
  9. 7.2.2 Pfizer Business Overview
  10. 7.2.3 Pfizer Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  12. 7.2.5 Pfizer Recent Developments
  13. 7.3 GlaxoSmithKline
  14. 7.3.1 GlaxoSmithKline Company Information
  15. 7.3.2 GlaxoSmithKline Business Overview
  16. 7.3.3 GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  18. 7.3.5 GlaxoSmithKline Recent Developments
  19. 7.4 Bayer
  20. 7.4.1 Bayer Company Information
  21. 7.4.2 Bayer Business Overview
  22. 7.4.3 Bayer Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Bayer Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  24. 7.4.5 Bayer Recent Developments
  25. 7.5 Synergy Pharmaceuticals
  26. 7.5.1 Synergy Pharmaceuticals Company Information
  27. 7.5.2 Synergy Pharmaceuticals Business Overview
  28. 7.5.3 Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  30. 7.5.5 Synergy Pharmaceuticals Recent Developments
  31. 7.6 Sucampo Pharmaceuticals
  32. 7.6.1 Sucampo Pharmaceuticals Company Information
  33. 7.6.2 Sucampo Pharmaceuticals Business Overview
  34. 7.6.3 Sucampo Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sucampo Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  36. 7.6.5 Sucampo Pharmaceuticals Recent Developments
  37. 7.7 Salix Pharmaceuticals
  38. 7.7.1 Salix Pharmaceuticals Company Information
  39. 7.7.2 Salix Pharmaceuticals Business Overview
  40. 7.7.3 Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  42. 7.7.5 Salix Pharmaceuticals Recent Developments
  43. 7.8 Roche Holding
  44. 7.8.1 Roche Holding Company Information
  45. 7.8.2 Roche Holding Business Overview
  46. 7.8.3 Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  48. 7.8.5 Roche Holding Recent Developments
  49. 7.9 Progenics Pharmaceuticals
  50. 7.9.1 Progenics Pharmaceuticals Company Information
  51. 7.9.2 Progenics Pharmaceuticals Business Overview
  52. 7.9.3 Progenics Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Progenics Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  54. 7.9.5 Progenics Pharmaceuticals Recent Developments
  55. 7.10 Ironwood Pharmaceuticals
  56. 7.10.1 Ironwood Pharmaceuticals Company Information
  57. 7.10.2 Ironwood Pharmaceuticals Business Overview
  58. 7.10.3 Ironwood Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Ironwood Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  60. 7.10.5 Ironwood Pharmaceuticals Recent Developments
  61. 7.11 Ferring International Center
  62. 7.11.1 Ferring International Center Company Information
  63. 7.11.2 Ferring International Center Business Overview
  64. 7.11.3 Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  66. 7.11.5 Ferring International Center Recent Developments
  67. 7.12 Chugai Pharmaceutical
  68. 7.12.1 Chugai Pharmaceutical Company Information
  69. 7.12.2 Chugai Pharmaceutical Business Overview
  70. 7.12.3 Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  72. 7.12.5 Chugai Pharmaceutical Recent Developments
  73. 7.13 Actavis
  74. 7.13.1 Actavis Company Information
  75. 7.13.2 Actavis Business Overview
  76. 7.13.3 Actavis Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Actavis Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  78. 7.13.5 Actavis Recent Developments
8 North America
  1. 8.1 North America Chronic Idiopathic Constipation (CIC) Drugs Market Size by Type
  2. 8.1.1 North America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Chronic Idiopathic Constipation (CIC) Drugs Price by Type (2021-2032)
  5. 8.2 North America Chronic Idiopathic Constipation (CIC) Drugs Market Size by Application
  6. 8.2.1 North America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Chronic Idiopathic Constipation (CIC) Drugs Price by Application (2021-2032)
  9. 8.3 North America Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country
  10. 8.3.1 North America Chronic Idiopathic Constipation (CIC) Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Chronic Idiopathic Constipation (CIC) Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Chronic Idiopathic Constipation (CIC) Drugs Market Size by Type
  2. 9.1.1 Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Chronic Idiopathic Constipation (CIC) Drugs Price by Type (2021-2032)
  5. 9.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Market Size by Application
  6. 9.2.1 Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Chronic Idiopathic Constipation (CIC) Drugs Price by Application (2021-2032)
  9. 9.3 Europe Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country
  10. 9.3.1 Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Chronic Idiopathic Constipation (CIC) Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Chronic Idiopathic Constipation (CIC) Drugs Market Size by Type
  2. 10.1.1 China Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Chronic Idiopathic Constipation (CIC) Drugs Price by Type (2021-2032)
  5. 10.2 China Chronic Idiopathic Constipation (CIC) Drugs Market Size by Application
  6. 10.2.1 China Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Chronic Idiopathic Constipation (CIC) Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Chronic Idiopathic Constipation (CIC) Drugs Market Size by Type
  2. 11.1.1 Asia Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Chronic Idiopathic Constipation (CIC) Drugs Price by Type (2021-2032)
  5. 11.2 Asia Chronic Idiopathic Constipation (CIC) Drugs Market Size by Application
  6. 11.2.1 Asia Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Chronic Idiopathic Constipation (CIC) Drugs Price by Application (2021-2032)
  9. 11.3 Asia Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country
  10. 11.3.1 Asia Chronic Idiopathic Constipation (CIC) Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Chronic Idiopathic Constipation (CIC) Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Chronic Idiopathic Constipation (CIC) Drugs Market Size by Type
  2. 12.1.1 SAMEA Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Chronic Idiopathic Constipation (CIC) Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Chronic Idiopathic Constipation (CIC) Drugs Market Size by Application
  6. 12.2.1 SAMEA Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Chronic Idiopathic Constipation (CIC) Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country
  10. 12.3.1 SAMEA Chronic Idiopathic Constipation (CIC) Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Chronic Idiopathic Constipation (CIC) Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Chronic Idiopathic Constipation (CIC) Drugs Value Chain Analysis
  2. 13.1.1 Chronic Idiopathic Constipation (CIC) Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Chronic Idiopathic Constipation (CIC) Drugs Production Mode & Process
  6. 13.2 Chronic Idiopathic Constipation (CIC) Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Chronic Idiopathic Constipation (CIC) Drugs Distributors
  9. 13.2.3 Chronic Idiopathic Constipation (CIC) Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst